BAYN.DE
XETRABayer AG
Healthcare · Drug Manufacturers - General
Verdict
signal 2 h agoNo buyable dip: 3.5% below its 30-day high. Nothing to do here.
Catalysts
3 h ago- News, last 10 days
- positive +0.435 articles
- Next earnings
- 03/11/2026 · in 47 days
- Last report
- 31/07/2026 +27.3% vs estimate
Trade levels
Why the engine says so
History for this ticker
Watch and alert
About Bayer AG
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
- Headquarters:
- Leverkusen, Germany
- 52-week range:
- €25.78 – €53.92
- Website:
- bayer.com
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search